Skip to main content
Erschienen in:

16.06.2022 | Original Article

Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma

verfasst von: Liang Wang, Jing Li, Dan Song, Lei Guo

Erschienen in: Pediatric Surgery International | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the efficacy of transcatheter arterial embolization (TAE) plus propranolol treatment for infantile hepatic hemangioma (IHH).

Methods

A retrospective study of symptomatic IHH and hemodynamic changes in IHH was conducted between 2016 and 2019.

Results

There were five boys and seven girls with diffuse lesions (n = 7) and multifocal lesions (n = 5). Hepatomegaly and abdominal distension (n = 6) were the predominant clinical presentations. Seven patients (58.3%) had multiple cutaneous hemangiomas. Pulmonary arterial hypertension, heart failure (n = 4), and hypothyroidism (n = 4) were observed. A total of 17 TAE procedures were performed in 12 IHH cases, with a technical success rate of 100%. All patients received standard propranolol orally, and one patient was orally administered metacortandracin. Two patients died of heart failure and multiple organ dysfunction caused by an enlarged liver. In addition, one patient was not reexamined after discharge. Of the remaining nine children, the average follow-up time was 10.78 months (range 2–28 months), and they all responded well to TAE combined with oral propranolol.

Conclusion

TAE combined with propranolol is safe and effective for the treatment of IHH, demonstrating low complication rates.
Literatur
1.
Zurück zum Zitat Iacobas I et al (2018) Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 203:294-300 e2CrossRef Iacobas I et al (2018) Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 203:294-300 e2CrossRef
3.
Zurück zum Zitat Zavras N et al (2020) Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 179(1):1–8CrossRef Zavras N et al (2020) Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 179(1):1–8CrossRef
4.
Zurück zum Zitat Razon MJ et al (1998) Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 5(2–3):189–195CrossRef Razon MJ et al (1998) Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation 5(2–3):189–195CrossRef
5.
Zurück zum Zitat Lerut J, Iesari S (2018) Vascular tumours of the liver: a particular story. Transl Gastroenterol Hepatol 3:62CrossRef Lerut J, Iesari S (2018) Vascular tumours of the liver: a particular story. Transl Gastroenterol Hepatol 3:62CrossRef
6.
Zurück zum Zitat Rialon KL et al (2015) Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg 50(5):837–841CrossRef Rialon KL et al (2015) Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg 50(5):837–841CrossRef
7.
Zurück zum Zitat Macdonald A et al (2020) Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg 275(1):e250–e255CrossRef Macdonald A et al (2020) Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg 275(1):e250–e255CrossRef
8.
Zurück zum Zitat Chatmethakul T et al (2016) Infantile hepatic hemangioendothelioma: an uncommon cause of persistent pulmonary hypertension in a newborn infant. AJP Rep 6(3):e260–e263CrossRef Chatmethakul T et al (2016) Infantile hepatic hemangioendothelioma: an uncommon cause of persistent pulmonary hypertension in a newborn infant. AJP Rep 6(3):e260–e263CrossRef
9.
Zurück zum Zitat Varrasso G et al (2017) Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report. Hepatology 66(1):283–285CrossRef Varrasso G et al (2017) Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report. Hepatology 66(1):283–285CrossRef
10.
Zurück zum Zitat Tsai MC, Liu HC, Yeung CY (2019) Efficacy of infantile hepatic hemangioma with propranolol treatment: a case report. Medicine (Baltimore) 98(4):e14078CrossRef Tsai MC, Liu HC, Yeung CY (2019) Efficacy of infantile hepatic hemangioma with propranolol treatment: a case report. Medicine (Baltimore) 98(4):e14078CrossRef
11.
Zurück zum Zitat Krowchuk DP et al (2019) Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 143(1):e20183475CrossRef Krowchuk DP et al (2019) Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 143(1):e20183475CrossRef
12.
Zurück zum Zitat Wang L et al (2020) Infantile hepatic hemangioendothelioma associated with pulmonary artery hypertension and cardiac insufficiency successfully treated with transcatheter arterial embolization and propranolol: a case report. Medicine 99(24):e20728CrossRef Wang L et al (2020) Infantile hepatic hemangioendothelioma associated with pulmonary artery hypertension and cardiac insufficiency successfully treated with transcatheter arterial embolization and propranolol: a case report. Medicine 99(24):e20728CrossRef
13.
Zurück zum Zitat Adams DM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257CrossRef Adams DM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257CrossRef
14.
Zurück zum Zitat Tian R et al (2020) Propranolol for infantile hepatic hemangioendothelioma: clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol 19(5):530–534CrossRef Tian R et al (2020) Propranolol for infantile hepatic hemangioendothelioma: clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol 19(5):530–534CrossRef
15.
Zurück zum Zitat Lekwuttikarn R, Josephs S, Teng JM (2019) Successful medical management of life-threatening hepatic hemangioma in neonates. Pediatrics 144(4):e20191339CrossRef Lekwuttikarn R, Josephs S, Teng JM (2019) Successful medical management of life-threatening hepatic hemangioma in neonates. Pediatrics 144(4):e20191339CrossRef
17.
Zurück zum Zitat Ozdemir ZC et al (2017) Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. Drug Discov Ther 11(3):161–164CrossRef Ozdemir ZC et al (2017) Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. Drug Discov Ther 11(3):161–164CrossRef
18.
Zurück zum Zitat Sarialioglu F et al (2017) A new perspective for infantile hepatic hemangioma in the age of propranolol: experience at Baskent University. Exp Clin Transplant 15(2):74–78PubMed Sarialioglu F et al (2017) A new perspective for infantile hepatic hemangioma in the age of propranolol: experience at Baskent University. Exp Clin Transplant 15(2):74–78PubMed
19.
Zurück zum Zitat Wang T et al (2015) Infantile hepatic hemangioendothelioma associated with congestive heart failure: two case reports with different outcomes. Medicine 94(52):e2344CrossRef Wang T et al (2015) Infantile hepatic hemangioendothelioma associated with congestive heart failure: two case reports with different outcomes. Medicine 94(52):e2344CrossRef
20.
Zurück zum Zitat Brown J, Arora R, Sethuraman U (2018) Distributive shock in a neonate with diffuse infantile hepatic hemangioma. J Emerg Med 54(1):e1–e3CrossRef Brown J, Arora R, Sethuraman U (2018) Distributive shock in a neonate with diffuse infantile hepatic hemangioma. J Emerg Med 54(1):e1–e3CrossRef
21.
Zurück zum Zitat Yang K et al (2019) Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 55(10):1194–1200CrossRef Yang K et al (2019) Efficacy of propranolol treatment in infantile hepatic haemangioma. J Paediatr Child Health 55(10):1194–1200CrossRef
22.
Zurück zum Zitat Al Tasseh F et al (2017) Diffuse hepatic hemangioma with single cutaneous hemangioma: an alerting occurrence. Clin Case Rep 5(6):887–890CrossRef Al Tasseh F et al (2017) Diffuse hepatic hemangioma with single cutaneous hemangioma: an alerting occurrence. Clin Case Rep 5(6):887–890CrossRef
23.
Zurück zum Zitat Aly MM et al (2015) Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Eur J Pediatr 174(11):1503–1509CrossRef Aly MM et al (2015) Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Eur J Pediatr 174(11):1503–1509CrossRef
24.
Zurück zum Zitat deLorimier AA et al (1967) Hepatic-artery ligation for hepatic hemangiomatosis. N Engl J Med 277(7):333–337CrossRef deLorimier AA et al (1967) Hepatic-artery ligation for hepatic hemangiomatosis. N Engl J Med 277(7):333–337CrossRef
25.
Zurück zum Zitat Dong W et al (2019) Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol 31(9):1079–1084CrossRef Dong W et al (2019) Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol 31(9):1079–1084CrossRef
26.
Zurück zum Zitat Warmann S et al (2003) Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 38(8):1177–1181CrossRef Warmann S et al (2003) Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg 38(8):1177–1181CrossRef
27.
Zurück zum Zitat Huang Y et al (2014) Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomas. Exp Ther Med 7(2):473–477CrossRef Huang Y et al (2014) Proapoptotic effect and the mechanism of action of pingyangmycin on cavernous hemangiomas. Exp Ther Med 7(2):473–477CrossRef
28.
Zurück zum Zitat Gaba RC, Schwind RM, Ballet S (2018) Mechanism of action, pharmacokinetics, efficacy, and safety of transarterial therapies using ethiodized oil: preclinical review in liver cancer models. J Vasc Interv Radiol 29(3):413–424CrossRef Gaba RC, Schwind RM, Ballet S (2018) Mechanism of action, pharmacokinetics, efficacy, and safety of transarterial therapies using ethiodized oil: preclinical review in liver cancer models. J Vasc Interv Radiol 29(3):413–424CrossRef
Metadaten
Titel
Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma
verfasst von
Liang Wang
Jing Li
Dan Song
Lei Guo
Publikationsdatum
16.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 8/2022
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-022-05143-w

Neu im Fachgebiet Pädiatrie

Podcast

Magendarminfekte: Dos and Don'ts bei Kleinkindern

Die Leitlinie zur akuten infektiösen Gastroenteritis wurde 2024 umfassend überarbeitet. Cola und Saft zur oralen Hydratation und einige Antidiarrhoika sollten vermieden werden. Von einem standardmäßigen Erregerpanel wird abgeraten. Die Hintergründe zu diesen und weiteren Empfehlungen erläutert Leitlinienkoordinator Prof. Carsten Posovszky.

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

ADHS-Kranke verlieren sieben Lebensjahre

  • 11.02.2025
  • ADHS
  • Nachrichten

Ein ADHS verkürzt die Lebenserwartung um rund sieben Jahre, bei Frauen sind es sogar fast neun Jahre. Ein Großteil der erhöhten Sterblichkeit lässt sich auf modifizierbare Risikofaktoren wie Alkohol, Rauchen und psychische Begleiterkrankungen zurückführen.

Abdominale CT bei Kindern: 40% mit Zufallsbefunden

Wird bei Kindern mit stumpfem Trauma eine CT des Bauchraums veranlasst, sind in rund 40% der Fälle Auffälligkeiten zu sehen, die nichts mit dem Trauma zu tun haben. Die allerwenigsten davon sind klinisch relevant.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.